HuGE Literature Finder
Records
1
-
30
| Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
| Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments. Oncology letters 2022 Oct 24 (4): 362. Zhou Lin, Li Huiwu, Yang Shuh |
| ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer. Thoracic cancer 2022 Oct . de Oliveira Cavagna Rodrigo, Zaniolo Beatriz Garbe, de Paula Flávia Escremim, Berardinelli Gustavo Noriz, Santana Iara, da Silva Eduardo Caetano Albino, Dias Josiane Mourão, Jacinto Alexandre Arthur, da Nóbrega Oliveira Rachid Eduardo Noleto, de Marchi Pedro, Leal Letícia Ferro, Reis Rui Manu |
| Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients. The Journal of thoracic and cardiovascular surgery 2022 Aug . Hashimoto Kohei, Ariyasu Ryo, Ichinose Junji, Matsuura Yosuke, Nakao Masayuki, Amino Yoshiaki, Uchibori Ken, Kitazono Satoru, Yanagitani Noriko, Okumura Sakae, Nishio Makoto, Mun Mingy |
| Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program. Seminars in oncology 2022 Jul . Jalal Shadia I, Guo Aixia, Ahmed Sara, Kelley Michael |
| CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma. Medicine 2022 Jul 101 (30): e29796. Zhang Sen, Li Na, Yang Yonghua, Li Yan, Lin Chenshi, Fu Guoquan, Cai J |
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| The Genomics of Colorectal Cancer in Populations with African and European Ancestry. Cancer discovery 2022 Feb . Myer Parvathi A, Lee Jessica K, Madison Russell W, Pradhan Kith, Newberg Justin Y, Isasi Carmen R, Klempner Samuel J, Frampton Garrett M, Ross Jeffrey S, Venstrom Jeffrey M, Schrock Alexa B, Das Sudipto, Augenlicht Leonard, Verma Amit, Greally John M, Raj Srilakshmi M, Goel Sanjay, Ali Siraj |
| Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions. The clinical respiratory journal 2022 Jan . Liu Qinghua, Huang Qingyan, Yu Zhikang, Wu Hemi |
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer. Emergency medicine international 2022 2022 6333282. Kong Wencui, Yu Zongyang, Wang Wenwu, Yang Jingrong, Wang Jingfang, Zhao Zhongqu |
| Genomic landscape of lung adenocarcinomas in different races. Frontiers in oncology 2022 12 946625. Shi Huashan, Seegobin Karan, Heng Fei, Zhou Kexun, Chen Ruqin, Qin Hong, Manochakian Rami, Zhao Yujie, Lou Yany |
| Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study. BMC pulmonary medicine 2022 1 22 (1): 32. Paliogiannis Panagiotis, Colombino Maria, Sini Maria Cristina, Manca Antonella, Casula Milena, Palomba Grazia, Pisano Marina, Doneddu Valentina, Zinellu Angelo, Santeufemia Davide, , Sotgiu Giovanni, Cossu Antonio, Palmieri Giusep |
| Oncogenic Alterations in Histologically Negative Lymph Nodes Are Associated with Prognosis of Patients with Stage I Lung Adenocarcinoma. Cancers 2022 2 14 (3): . Tian Yiping, Lai Qian, Zheng Yuansi, Ying Lisha, Wang Canming, Jin Jiaoyue, Huang Minran, Wu Yingxue, Li Huizhang, Zhang Jianjun, Su D |
| Prevalence of targeted therapy-related genetic variations in NSCLC and their relationship with clinicopathological characteristics. PloS one 2022 17 (1): e0262822. Li Fanghua, Ye Peng, Cai Peiling, Dong Dandan, Zhang Yihao, Yang Yue, Sun Xingwa |
| Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma. Translational cancer research 2022 2 10 (6): 2859-2872. Liu Libao, Xu Shilei, Huang Lei, He Jinyuan, Liu Gang, Ma Shaohong, Weng Yimin, Huang Shaoho |
| Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma. Thoracic cancer 2021 Oct . Zhang Huan, Shan Guangyao, Cai Benjie, Bi Guoshu, Chen Zhencong, Liang Jiaqi, Besskaya Valeria, Zheng Yuansheng, Guo Weigang, Wang Lin, Xu Songtao, Zhan Che |
| Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2021 Sep 161 163-170. Takamochi Kazuya, Hara Kieko, Hayashi Takuo, Kohsaka Shinji, Takahashi Fumiyuki, Suehara Yoshiyuki, Suzuki Ken |
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis. Pathology, research and practice 2021 Jul 224 153551. Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Neurosurgical resection for locally recurrent brain metastasis. Neuro-oncology 2021 Jul . Hulsbergen Alexander F C, Abunimer Abdullah M, Ida Fidelia, Kavouridis Vasileios K, Cho Logan D, Tewarie Ishaan A, Mekary Rania A, Schucht Philippe, Phillips John G, Verhoeff Joost J C, Broekman Marike L D, Smith Timothy |
| Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis. Cancer treatment and research communications 2021 Jul 28 100440. Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shi |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| The relationship between PD-L1 expression and tumor driver gene mutations and survival in non small cell lung carcinoma. Polish journal of pathology : official journal of the Polish Society of Pathologists 2021 72 (3): 222-228. Chan Kin, Vong Hong, Chu Wai, Cheng Kun, Zhong Xue, Wen Ji |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma. OncoTargets and therapy 2021 14 2953-2965. Wang Hao, Chen Shanhao, Meng Die, Wu Chunyan, Zhu Junjie, Jiang Minlin, Ning Jing, Wu Shengyu, Wu Lijia, Li Jingjie, Chen Bin, Zhao Sha, Li Wei, Yu Jia, Fang Qiyu, Zhu Jun, Zhao Wencheng, He Yayi, Zhou Caic |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 26, 2023
- Content source: